Literature DB >> 2153271

The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity.

L Hansen1, D Salmon, D Galasko, E Masliah, R Katzman, R DeTeresa, L Thal, M M Pay, R Hofstetter, M Klauber.   

Abstract

Thirty-six clinically diagnosed and pathologically confirmed Alzheimer's disease (AD) patients included 13 with cortical and subcortical Lewy bodies (LBs). The patients with LBs appeared to constitute a distinct neuropathologic and clinical subset of AD, the Lewy body variant (LBV). The LBV group showed gross pallor of the substantia nigra, greater neuron loss in the locus ceruleus, substantia nigra, and substantia innominata, lower neocortical ChAT levels, and fewer midfrontal tangles than did the pure AD group, along with a high incidence of medial temporal lobe spongiform vacuolization. Analysis of neuropsychological tests from 9 LBV subjects and 9 AD patients matched for age and degree of dementia revealed greater deficits in attention, fluency, and visuospatial processing in the LBV group. Similar comparisons of neurologic examinations showed a significant increase in masked facies; in addition there was an increase in essential tremor, bradykinesia, mild neck rigidity, and slowing of rapid alternating movements in the LBV group. Extremity rigidity, flexed posture, resting tremor, or other classic parkinsonian features were not characteristic of the LBV patient. In some cases, it may be possible to diagnose LBV premortem on the basis of the clinical and neuropsychological features.

Entities:  

Mesh:

Year:  1990        PMID: 2153271     DOI: 10.1212/wnl.40.1.1

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  167 in total

1.  Pentagon copying is more impaired in dementia with Lewy bodies than in Alzheimer's disease.

Authors:  T A Ala; L F Hughes; G A Kyrouac; M W Ghobrial; R J Elble
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-04       Impact factor: 10.154

2.  Familial associations of Alzheimer disease and essential tremor with Parkinson disease.

Authors:  S Costello; Y Bordelon; J Bronstein; B Ritz
Journal:  Eur J Neurol       Date:  2010-03-17       Impact factor: 6.089

3.  Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline.

Authors:  Lani K Clinton; Mathew Blurton-Jones; Kristoffer Myczek; John Q Trojanowski; Frank M LaFerla
Journal:  J Neurosci       Date:  2010-05-26       Impact factor: 6.167

4.  Cognitive tests aid in clinical differentiation of Alzheimer's disease versus Alzheimer's disease with Lewy body disease: Evidence from a pathological study.

Authors:  Martina Azar; Silvia Chapman; Yian Gu; James B Leverenz; Yaakov Stern; Stephanie Cosentino
Journal:  Alzheimers Dement       Date:  2020-06-19       Impact factor: 21.566

Review 5.  New insight into neurodegeneration: the role of proteomics.

Authors:  Ramavati Pal; Guido Alves; Jan Petter Larsen; Simon Geir Møller
Journal:  Mol Neurobiol       Date:  2013-12-10       Impact factor: 5.590

6.  Structural basis of the interplay between α-synuclein and Tau in regulating pathological amyloid aggregation.

Authors:  Jinxia Lu; Shengnan Zhang; Xiaojuan Ma; Chunyu Jia; Zhenying Liu; Chengan Huang; Cong Liu; Dan Li
Journal:  J Biol Chem       Date:  2020-04-13       Impact factor: 5.157

7.  Effect of α-synuclein on amyloid β-induced toxicity: relevance to Lewy body variant of Alzheimer disease.

Authors:  Rosa Resende; Sueli C F Marques; Elisabete Ferreiro; Isaura Simões; Catarina R Oliveira; Cláudia M F Pereira
Journal:  Neurochem Res       Date:  2013-02-07       Impact factor: 3.996

8.  The new Qualitative Scoring MMSE Pentagon Test (QSPT) as a valid screening tool between autopsy-confirmed dementia with Lewy bodies and Alzheimer's disease.

Authors:  Micaela Mitolo; David P Salmon; Simona Gardini; Douglas Galasko; Enzo Grossi; Paolo Caffarra
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

9.  Familial dementia with Lewy bodies with an atypical clinical presentation.

Authors:  Lauren T Bonner; Debby W Tsuang; Monique M Cherrier; Charisma J Eugenio; Q Du Jennifer; Ellen J Steinbart; Pornprot Limprasert; Albert R La Spada; Benjamin Seltzer; Thomas D Bird; James B Leverenz
Journal:  J Geriatr Psychiatry Neurol       Date:  2003-03       Impact factor: 2.680

10.  Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand.

Authors:  Z Walker; D C Costa; R W H Walker; K Shaw; S Gacinovic; T Stevens; G Livingston; P Ince; I G McKeith; C L E Katona
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-08       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.